Skip to content

    Lung Disease & Respiratory Health Center

    Font Size
    A
    A
    A

    FDA Rethinks Spiriva Stroke Warning

    Spiriva Inhaler Not Linked to Stroke, New Study Suggests
    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    Oct. 9, 2008 – The FDA is reconsidering its recent warning that the lung disease drug Spiriva might raise stroke risk.

    The warning came after Spiriva maker Boehringer Ingelheim analyzed pooled data from 29 Spiriva studies. These studies suggested that for every 1,000 patients taking Spiriva, there were two extra cases of stroke.

    Now there's new data from the four-year UPLIFT study of some 6,000 patients with chronic obstructive pulmonary disease (COPD). The patients -- average age 65 -- took Spiriva or placebo in addition to other types of respiratory drugs.

    There were 82 strokes among the 2,987 patients taking Spiriva and 80 strokes among the 3,006 patients getting an inactive placebo. The difference is not statistically significant.

    The FDA says it will take several months for it to finish it's review of the huge amount of data from the UPLIFT study. At that time, the federal agency says it will release all existing data on Spiriva and stroke risk.

    Today on WebMD

    man coughing
    You may not even know you have it.
    blood clot
    Signs of this potentially fatal complication.
     
    man coughing
    When a cold becomes bronchitis.
    human lungs
    Causes behind painful breathing, fluid buildup.
     

    chest x-ray
    Slideshow
    Bronchitis Overview
    SLIDESHOW
     
    Copd Myth Fact Quiz
    QUIZ
    Energy Boosting Foods
    SLIDESHOW
     

    lungs
    Article
    smokestacks
    Article
     
    woman coughing
    Article
    Lung xray and caduceus
    Article